Hydrogen-Releasing Nanosheets Enhanced Melanoma Treatment in Lab Studies
Local Delivery of Molecular Hydrogen by Fluorinated Zeolitic Imidazole Framework Nanosheets Boosts Cancer Immunotherapy
Research hubs: Immune System · Skin & Dermatology System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (cell culture)
- Authors
- Xiang Liu, Weidong Wang, Tianze Wu, Jianing Li, Yimin Gong, Dan Luo, Xianling Guo, Mingli Deng, Yannan Yang
- Journal
- ACS Applied Materials & Interfaces
- Year
- 2025
- PMID
- 40864154
- Study Type
- Cell Culture
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 0 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
A special hydrogen-releasing nanoparticle boosts the effectiveness of cancer immunotherapy by helping immune cells better recognize and attack tumors.
Key Finding
Hydrogen gas delivered via specialized nanoparticles enhanced the effectiveness of cancer immunotherapy drugs, achieving 83-90% tumor inhibition in melanoma models when combined with anti-CD47 and anti-PD-L1 antibodies.
Summary
Researchers developed a nanoparticle system that delivers hydrogen gas directly to tumors to enhance cancer immunotherapy. In laboratory and animal melanoma models, the hydrogen-releasing nanoparticles damaged tumor cells and made them more visible to immune system antibodies. When combined with existing immunotherapy drugs, this approach achieved 83-90% tumor shrinkage, suggesting hydrogen gas delivery may help overcome resistance to standard cancer treatments.
Practical Takeaway
This is early-stage laboratory and animal research, not human studies, so it cannot yet inform consumer decisions about hydrogen water. The study used a specialized nanoparticle delivery system, not the hydrogen water products available to consumers. While the results are promising for future cancer treatments, much more research is needed before any clinical applications would be possible.
Abstract (excerpt)
Identifying strategies to improve the efficacy of the immune checkpoint blockade (ICB) remains a major clinical need. Based on the high tissue penetration capability of hydrogen molecules (H2) and their immunomodulatory effects, this work proposes a local gas delivery strategy targeting the tumor…